Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study

C Patruno, M Napolitano, G Argenziano… - Journal of the …, 2021 - Wiley Online Library
Background Treatment of moderate‐to‐severe atopic dermatitis (AD) in the elderly may be
challenging, due to side‐effects of traditional anti‐inflammatory drugs and to comorbidities …
被引用次数：89 相关文章
[PDF] academia.edu

[PDF][PDF] Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study

C Patruno, M Napolitano, G Argenziano, K Peris… - 2020 - academia.edu
Background Treatment of moderate-to-severe atopic dermatitis (AD) in the elderly may be
challenging, due to side-effects of traditional anti-inflammatory drugs and to comorbidities …

Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study

C Patruno, M Napolitano, G Argenziano… - JOURNAL OF THE …, 2020 - iris.unime.it
Treatment of moderate-to-severe atopic dermatitis (AD) in the elderly may be challenging,
due to side-effects of traditional anti-inflammatory drugs and to comorbidities often found in …

Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study

C Patruno, M Napolitano, G Argenziano, K Peris… - 2021 - ricerca.unityfvg.it
Background: Treatment of moderate-to-severe atopic dermatitis (AD) in the elderly may be
challenging, due to side-effects of traditional anti-inflammatory drugs and to comorbidities …

Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study.

C Patruno, M Napolitano, G Argenziano… - Journal of the …, 2021 - europepmc.org
Background Treatment of moderate-to-severe atopic dermatitis (AD) in the elderly may be
challenging, due to side-effects of traditional anti-inflammatory drugs and to comorbidities …

Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study

C Patruno, M Napolitano, G Argenziano… - JOURNAL OF THE …, 2021 - iris.unito.it
Background: Treatment of moderate-to-severe atopic dermatitis (AD) in the elderly may be
challenging, due to side-effects of traditional anti-inflammatory drugs and to comorbidities …

Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study

C Patruno, M Napolitano, G Argenziano… - JOURNAL OF THE …, 2021 - iris.unibs.it
Background Treatment of moderate-to-severe atopic dermatitis (AD) in the elderly may be
challenging, due to side-effects of traditional anti-inflammatory drugs and to comorbidities …

Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study

C Patruno, M Napolitano, G Argenziano… - JOURNAL OF THE …, 2020 - publicatt.unicatt.it
Background: Treatment of moderate-to-severe atopic dermatitis (AD) in the elderly may be
challenging, due to side-effects of traditional anti-inflammatory drugs and to comorbidities …

Dupilumab therapy of atopic dermatitis of the elderly. A multi-centre, real-life study

C Patruno, M Napolitano, G Argenziano… - JOURNAL OF THE …, 2020 - iris.uniroma1.it
Background: Treatment of moderate-to-severe atopic dermatitis in the elderly may be
challenging, due to side effects of traditional anti-inflammatory drugs and to comorbidities …

Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study

C Patruno, M Napolitano, G Argenziano… - JOURNAL OF THE …, 2021 - sfera.unife.it
Background: Treatment of moderate-to-severe atopic dermatitis (AD) in the elderly may be
challenging, due to side-effects of traditional anti-inflammatory drugs and to comorbidities …